# Abbott Probability Of Bankruptcy

ABT | Stock | ## USD 111.48 0.99 0.90% |

Abbott | Probability Of Bankruptcy |

**B**in 2022, whereas Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop slightly above 10.6

**B**in 2022.

## Abbott Probability Of Bankruptcy Analysis

Abbott Laboratories' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.Probability Of Bankruptcy | = | Normalized | | Z-Score |

## Current Abbott Laboratories Probability Of Bankruptcy | 5% |

Most of Abbott Laboratories' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abbott Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of Abbott Laboratories probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Abbott Laboratories odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Abbott Laboratories financial health.

Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth YOY 0.73 | Market Capitalization 193.5 B | Quarterly Revenue Growth YOY 0.1 | Return On Assets 0.0896 | Return On Equity 0.24 |

The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Abbott Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

## Abbott Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Abbott Laboratories is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Abbott Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Abbott Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Abbott Laboratories' interrelated accounts and indicators.

**Click cells**to compare fundamentals

The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.

Compare to competition |

Based on the latest financial disclosure, Abbott Laboratories has a Probability Of Bankruptcy of 5.0%. This is 88.45% lower than that of the Healthcare sector and 87.86% lower than that of the Medical Devices industry. The probability of bankruptcy for all United States stocks is 87.45% higher than that of the company.

## Abbott Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abbott Laboratories' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abbott Laboratories could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics of similar companies.Abbott Laboratories is currently under evaluation in probability of bankruptcy category among related companies.

## Abbott Laboratories Main Bankruptcy Drivers

2017 | 2018 | 2019 | 2020 | 2021 | 2022 (projected) | ||

Return on Average Assets | 0.007 | 0.034 | 0.054 | 0.065 | 0.096 | 0.0765 | |

Asset Turnover | 0.38 | 0.44 | 0.47 | 0.5 | 0.58 | 0.57 | |

Total Debt | 27.92 B | 19.57 B | 18.14 B | 18.75 B | 18.05 B | 19.17 B | |

Total Liabilities | 45.15 B | 36.45 B | 36.59 B | 39.55 B | 39.17 B | 39.68 B | |

Current Liabilities | 8.91 B | 9.01 B | 10.86 B | 11.91 B | 13.11 B | 11.43 B | |

Total Assets | 76.25 B | 67.17 B | 67.89 B | 72.55 B | 75.2 B | 74.56 B | |

Current Assets | 20.15 B | 14.63 B | 15.67 B | 20.44 B | 24.24 B | 21.33 B | |

Net Cash Flow from Operations | 5.57 B | 6.3 B | 6.14 B | 7.9 B | 10.53 B | 9.12 B | |

Weighted Average Shares | 1.74 B | 1.76 B | 1.77 B | 1.77 B | 1.77 B | 1.88 B | |

Weighted Average Shares Diluted | 1.75 B | 1.77 B | 1.78 B | 1.79 B | 1.79 B | 1.9 B |

## Abbott Laboratories ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Abbott Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Abbott Laboratories' managers, analysts, and investors.Environment Score | Governance Score | Social Score |

## Abbott Fundamentals

Return On Equity | 22.26 % | |||

Return On Asset | 8.56 % | |||

Profit Margin | 18.78 % | |||

Operating Margin | 22.96 % | |||

Current Valuation | 199.77 B | |||

Shares Outstanding | 1.77 B | |||

Shares Owned by Insiders | 0.73 % | |||

Shares Owned by Institutions | 75.55 % | |||

Number of Shares Shorted | 14.22 M | |||

Price to Earning | 27.11 X | |||

Price to Book | 5.61 X | |||

Price to Sales | 4.24 X | |||

Revenue | 45.55 B | |||

Gross Profit | 25.01 B | |||

EBITDA | 13.83 B | |||

Net Income | 8.53 B | |||

Cash and Equivalents | 8.16 B | |||

Cash per Share | 4.66 X | |||

Total Debt | 17.12 B | |||

Debt to Equity | 0.48 % | |||

Current Ratio | 1.85 X | |||

Book Value Per Share | 19.47 X | |||

Cash Flow from Operations | 9.96 B | |||

Short Ratio | 2.64 X | |||

Earnings Per Share | 4.03 X | |||

Price to Earnings To Growth | 1.99 X | |||

Number of Employees | 113 K | |||

Beta | 0.74 | |||

Market Capitalization | 193.19 B | |||

Total Asset | 41.25 B | |||

Retained Earnings | 26.88 B | |||

Working Capital | 4.97 B | |||

Current Asset | 14.15 B | |||

Current Liabilities | 9.19 B | |||

Z Score | 7.6 | |||

Five Year Return | 1.54 % | |||

Last Dividend Paid | 1.88 |

## About Abbott Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Abbott Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbott Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbott Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 113000 people.
## Be your own money manager

Our tools can tell you how much better you can do entering a position in Abbott Laboratories without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.## Did you try this?

### Run Transaction History Now

## Transaction HistoryView history of all your transactions and understand their impact on performance |

All Next | Launch Module |

## Pair Trading with Abbott Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.

The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Please continue to Abbott Laboratories Piotroski F Score and Abbott Laboratories Altman Z Score analysis. Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

## Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.

Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | Go | |

Fund ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges | Go | |

Price TransformationUse Price Transformation models to analyze depth of different equity instruments across global markets | Go | |

Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk | Go | |

Money ManagersScreen money managers from public funds and ETFs managed around the world | Go | |

Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | Go | |

Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | Go | |

Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios | Go | |

Stock ScreenerFind equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | Go | |

Equity ValuationCheck real value of public entities based on technical and fundamental data | Go | |

CEO DirectoryScreen CEOs from public companies around the world | Go |

Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth YOY 0.73 | Market Capitalization 193.5 B | Quarterly Revenue Growth YOY 0.1 | Return On Assets 0.0896 | Return On Equity 0.24 |

The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Abbott Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.